As a part of the Annual leading event, PharmaCon China series, Informa Life Science/IBC Asia is organising Clinical Trials Site Selection and Quality China – which will be the FIRST and ONLY conference that focuses fully of site selection, quality assurance for sites, collaboration and engagement between sites and trial sponsors to identify key challenges and accelerate quality clinical trial programmes in China.

作为制药与医药峰会(PharmaCon)中国系列年度盛会的一部分,IBC亚洲正在筹备召开“中国临床试验点选择和质量会议”—— 这将是首个也是唯一全面探讨以下议题的会议:试验点选择、试验点质量保证、试验点和试验赞助方合作并且共同参与以帮助发现中国面临的关键挑战,从而加快推动中国的优质临床试验计划。


 

Key Highlights / 关键亮点

Case Studies
Post Regulatory Updates, Impact on Site Selection and Quality in China

案例研究
监管执行后的最新进展以及对中国临床试验点选择和质量的影响

Industry Dialogue
Commercial, Regulatory and Operational Outlook for Clinical Trials in China

行业对话
中国临床试验的商业、监管和运营展望

Site Selection and Feasibility
Selecting Right Site with Right Subpopulation, Decision Making

试验点选择和可行性
选择有合适亚群体的恰当临床试验点并做出正确决策

Site Management
Ensuring Data Transparency, Data Integrity

试验点管理
确保数据透明性及完整性

Hear from Private Investigators
How to Ensure Data Integrity for Trial Sites in China

了解私立调查方的观点
如何确保中国试验点的数据完整性?

Sites as Partners
Improving Communication between Sponsors, CROs and Sites

与试验点管理方紧密合作
提升与赞助商、合约研究组织(CRO)和中心管理方之间的沟通



Featured Speakers

Wu Tai Xiang
Director, Chinese Clinical Trials Registry, China

Lau Lit Fui
President and COO, CVie Therapeutics Limited, Taiwan

Rebecca Dai
Head Clinical Project Management – Primary Care & Women’s Healthcare, Clinical Development Operations, Bayer Pharmaceuticals, China

Paul Kong
Director of Clinical Operations, Fibrogen, China

Xin Zhang
Senior Director, Clinical Operations, Shanghai Henlius Biotech Co Ltd, China

Zhao Xianfeng
Head of Clinical Research, Abbott Nutrition R&D, China

Isabel Han
Executive Director, Clinical Operations, Denovo Biopharma, China


Hear from past participants

“I found the meeting quite robust and certainly had a good and healthy exchange of knowledge. I would certainly be happy to participate in future initiatives and explore how these great meetings can be made more interactive and rewarding.”

Regional Medical Leader, Oncology, Asia Pacific Medical Affairs, Roche Pharmaceuticals
“Thank you for providing the platform which allows all experts to exchange and discuss thoughtful viewpoint inside of clinical trials industry. Your organization always impresses me.”

Vice Chairman, Asia Pacific, PAREXEL International
“Comprehensive conference covered most areas concerned by pharmaceutics, CRO and clinical trial centers in China. Different from clinical trial event, which often focus on one or two aspects of clinical trial.“

Director, Clinical Operations, TenNor Therapeutics
“This is a very worthwhile conference. In addition to the sessions, there are networking breaks that allow interaction between attendees at one of three sessions that take place concurrently.“

Director, Clinical Development and Medical Affairs, Respiratory Therapeutic Area, Boehringer Ingelheim Pharmaceuticals
“A very diverse panel of speakers and attendees.”

CEO, BARC Central Labs
“Very friendly and supportive staff - made the event a “hit” for us!”

Director, Business Development, Asia, INC Research
“Thanks so much for fantastic support before and during the event. It was a true pleasure working with you!”

Marketing Manager, APAC, PAREXEL International
“Footfall was good and the quality of people were great. Would recommend to our marketing manager”

Global Business Development Manager, MESM Global
“Very nicely done. Look forward to participating again next year”

Vice President, Business Development and General Manager, Asia, Indipharm

 

Part of

Co-Located Events

Contact Us

Bronze Sponsor

Exhibitors